Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
WHO chief says 12 dead in strike on Lebanon's primary healthcare center
India seeks passage of more vessels after some pass through Strait of Hormuz
Israeli forces kill four Palestinians in West Bank, Palestinian health authorities say
US embassy in Baghdad hit in missile attack, security sources say
Twenty people, including soldiers and civilians, killed in armed attack in Nigeria
US orders non-emergency personnel to leave Oman amid regional conflict
US identifies six service members killed in plane crash over Iraq
Israel threatens to strike ambulances in Lebanon in Hezbollah fighting
